Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.23.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Accounts receivable, net of allowance for credit losses $ 764 $ 945
Preferred stock, shares authorized 50,000,000 0
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, shares authorized 300,000,000 151,717,882
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares issued 142,503,771 78,601,283
Common stock, shares outstanding 142,503,771 78,601,283
Redeemable Convertible Preferred Stock    
Redeemable convertible preferred stock, shares authorized 0 20,526,878
Redeemable convertible preferred stock, par value $ 0.0001 $ 0.0001
Redeemable convertible preferred stock, shares issued 0 10,947,686
Redeemable convertible preferred stock, shares outstanding 0 10,947,686